Released by Kalorama Information of New York, the study “Gene Expression Profiling Markets” forecasts that the gene expression analysis market will be worth nearly $2.5 billion by 2012. It states that real-time PCR, microarray improvements and clinical applications will cause double-digit growth for the next five years. The increase will result from improved standardization and compatibility among technologies, as well as from increasing clarity regarding regulatory issues.